Results 61 to 70 of about 6,379 (226)
Der Nachweis von Epstein-Barr-Virus-Genomen in der Ohrspeicheldrüse = Evidence for the persistence of Epstein-Barr-virus in the parotid gland (author's transl.) [PDF]
, 1981 EBV is associated with B-lymphocytes. It is, however, not clear whether spontaneous activation of EBV genomes in carrier lymphocytes, which are present in the lymphocyte rich area of the oropharynx, is responsible for lifelong persistence of antibody ...
Wilmes, E., Wolf, Hans J.
core +1 more source
Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen [PDF]
Journal of Virology, 1983 Marek's disease herpesvirus A antigen (MDHV-A) was identified as a 61,000- to 65,000-dalton glycoprotein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis after immunoprecipitation from the culture medium of both [35S]methionine- and [14C]glucosamine-labeled infected cells by specific rabbit serum directed against MDHV-A.
C, Glaubiger, K, Nazerian, L F, Velicer
openaire +2 more sources
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
British Journal of Pharmacology, EarlyView.Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander +5 more
wiley +1 more source
Development of a cDNA array for chicken gene expression analysis [PDF]
, 2005 Background: The application of microarray technology to functional genomic analysis in the chicken has been limited by the lack of arrays containing large numbers of genes.
Burnside, Joan +7 more
core +2 more sources
Psilocybin as a novel treatment for chronic pain
British Journal of Pharmacology, EarlyView.Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey +3 more
wiley +1 more source
Vaccines, 2020 Marek’s disease (MD) is a lymphoproliferative disease in chickens caused by Marek’s disease virus (MDV), a highly oncogenic alphaherpesvirus. Since 1970, MD has been controlled through widespread vaccination of commercial flocks.
Supawadee Umthong +2 more
doaj +1 more source
Scientific Reports, 2023 Genetically resistant or susceptible chickens to Marek’s disease (MD) have been widely used models to identify the molecular determinants of these phenotypes.
Wesley C. Warren +8 more
doaj +1 more source
Replication of Marek's Disease Virus Is Dependent on Synthesis of De Novo Fatty Acid and Prostaglandin E2 [PDF]
, 2019 Marek’s disease virus (MDV) causes deadly lymphoma and induces an imbalance of the lipid metabolism in infected chickens. Here, we discovered that MDV activates the fatty acid synthesis (FAS) pathway in primary chicken embryo fibroblasts (CEFs).
Behboudi, Shahriar +3 more
core +1 more source
Marek’s disease virus and skin interactions [PDF]
Veterinary Research, 2014 Marek's disease virus (MDV) is a highly contagious herpesvirus which induces immunosuppression and T-cell lymphoma in chicken. This virus still circulates in flocks despite forty years of vaccination, with important economical losses at the world level.
Couteaudier, Mathilde +1 more
openaire +5 more sources
Psychedelics, entactogens and psychoplastogens for depression and related disorders
British Journal of Pharmacology, EarlyView.Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source